Huons Group Launches Professional Management System Across All Subsidiaries... "Strengthening Responsible Management"
[Asia Economy Reporter Lee Gwan-joo] Huons Group has entered a professional management system across all its group companies.
According to Huons Group on the 1st, on the 31st of last month, Huons Global and Hu M&C (formerly Huons Blossom) appointed CEO Song Soo-young and CEO Kim Joon-chul, respectively, through their regular shareholders' meetings and board of directors.
With this, all nine affiliates of Huons Group have established a professional management system. Each company will practice responsible management under the CEO system and respond flexibly and swiftly to rapidly changing global situations and policies.
In particular, Huons Global, the holding company of Huons Group, has introduced a professional management system for the first time in its 57-year history. Huons Global will oversee the innovation and reform of the management system across all group companies, amplify the brand value of Huons Group, and support the independent management of each business company. It will also focus on future sustainable growth represented by ESG (Environmental, Social, and Governance), helping the group fulfill its responsibilities as a social enterprise and practice universal human values.
Song Soo-young, CEO of Huons Global, said, “In the new era following COVID-19 and the Fourth Industrial Revolution era, we plan to implement management innovation throughout the group for Huons Group’s future sustainable growth and a new leap forward. We will grow into a true global healthcare group equipped with future responsiveness.”
Group owner Vice Chairman Yoon Sung-tae will assume the position of chairman through the group’s regular personnel appointments. Chairman Yoon plans to gather and coordinate opinions to ensure all group companies have future responsiveness and pursue sustainable growth, while presenting the group’s new vision and direction. Externally, he will serve as chairman of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association until 2023, enhancing the status of the pharmaceutical and bio industry and working together to solve various challenges faced by domestic pharmaceutical and bio companies in the endemic era and striving for mutual growth.
Hot Picks Today
"Only Two Per Person" Garbage Bag Crisis Was Just Yesterday... Japan Also Faces Shortage Anxiety
- "Samsung Electronics Employee with 100 Million Won Salary Receiving 600 Million Won Bonus... Estimated Tax Revealed"
- Lived as Family for Over 30 Years... Daughter-in-Law Cast Aside After Husband's Death
- 'Will Demand Finally Decline Due to High Prices?'... "I'll Just Enjoy Nearby Trips" as Japan and China See a Surge
- "Wore It Once, Then This? White Spots All Over 4.15 Million Won Prada Jacket... 'Full Refund Ordered'"
A Huons Group official stated, “Huons Group achieved remarkable growth in the history of domestic pharmaceutical and bio industries through stable management under owner management and quick decision-making and determination. We judged that the current time, which heralds a new era, is the right time for a major turning point for Huons Group, so we promoted the transition of the management system of the holding company Huons Global, and Hu M&C also appointed a new CEO.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.